erlotinib hydrochloride has been researched along with chitosan in 8 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 27,648 | 232 | 21,257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Jia, L; Li, F; Liu, J; Lv, T; Mei, H; Nie, H; Xie, X; Zhang, H | 1 |
| Lakkadwala, S; Singh, J | 1 |
| Dua, K; Dureja, H; Pandey, P | 1 |
| Bakshi, HA; Chellappan, DK; Dua, K; Dureja, H; Pandey, P; Tambuwala, MM | 1 |
| Barar, J; Erfan-Niya, H; Fathi, M; Omidi, Y | 1 |
| Chen, H; Gao, Y; Li, B; Li, X; Li, Z; Liu, W; Ye, J; Zheng, Y; Zhu, L | 1 |
| Hu, X; Jeevithan, E; Mariadoss, AVA; Saravanakumar, K; Sathiyaseelan, A; Shin, S; Wang, MH | 1 |
| Chen, H; Gao, Y; Li, Z; Wang, J; Zhang, L; Zhang, P; Zhu, L | 1 |
8 other study(ies) available for erlotinib hydrochloride and chitosan
| Article | Year |
|---|---|
Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Cell Cycle; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Screening Assays, Antitumor; Erlotinib Hydrochloride; Humans; Liposomes | 2017 |
Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Chitosan; Doxorubicin; Drug Delivery Systems; Endothelial Cells; Erlotinib Hydrochloride; Glioblastoma; Humans; Liposomes; Models, Biological; Neuroglia; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Receptors, Transferrin; Tissue Scaffolds; Transferrin | 2019 |
Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
Topics: A549 Cells; Antineoplastic Agents; Chemical Phenomena; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Erlotinib Hydrochloride; Humans; Kinetics; Nanoparticles; Particle Size | 2019 |
Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Topics: A549 Cells; Antineoplastic Agents; Chitosan; Diffusion; Drug Carriers; Drug Compounding; Drug Liberation; Erlotinib Hydrochloride; Humans; Kinetics; Nanoparticles; Particle Size; Polyethylene Glycols | 2019 |
Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Female; Humans; Magnetite Nanoparticles; Methotrexate; Ovarian Neoplasms | 2020 |
Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Combined Modality Therapy; Drug Carriers; Erlotinib Hydrochloride; Female; Fluorescent Dyes; Gene Transfer Techniques; Humans; Indoles; Infrared Rays; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photothermal Therapy; Plasmids; Precision Medicine; RNA, Small Interfering; Survivin; Xenograft Model Antitumor Assays | 2020 |
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Topics: A549 Cells; Animals; Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Oligodeoxyribonucleotides; Reactive Oxygen Species; Signal Transduction | 2020 |
An intelligent hypoxia-relieving chitosan-based nanoplatform for enhanced targeted chemo-sonodynamic combination therapy on lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chitosan; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Molecular Targeted Therapy | 2021 |